Major Drugs - Salt Lake City, UT, US
GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
Gmail
WordPress.org
Google Font API
Mobile Friendly
GoDaddy Hosting